Overview

  • Product nameAnti-ABHD12 antibody
    See all ABHD12 primary antibodies
  • Description
    Goat polyclonal to ABHD12
  • Specificityab81906 is expected to recognize isoform a (NP_001035937.1) only.
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Mouse, Rat
    Predicted to work with: Human, Cynomolgus Monkey
  • Immunogen

    Synthetic peptide:

    C-REFLGKSEPEHQH

    , corresponding to C terminal amino acids 386-398 of Human ABHD12 (NP_001035937.1).

  • Positive control
    • Mouse Brain and Rat Brain lysates.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris saline, pH 7.3
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesab81906 is purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • ClonalityPolyclonal
  • IsotypeIgG

Applications

Our Abpromise guarantee covers the use of ab81906 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
ELISA
  • Application notesPeptide ELISA: Antibody detection limit dilution 1/32000.
    WB: Use at a concentration of 0.3 - 1 µg/ml. Detects a band of approximately 40 kDa (predicted molecular weight: 45 kDa).


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionHas 2-arachidonoylglycerol hydrolase activity (By similarity). May be a regulator of endocannabinoid signaling pathways.
    • Involvement in diseaseDefects in ABHD12 are the cause of polyneuropathy hearing loss ataxia retinitis pigmentosa and cataract (PHARC) [MIM:612674]. PHARC is a slowly progressive neurologic disorder with a variable phenotype resembling Refsum disease. Clinical features include sensorineural hearing loss, visual problems related to cataracts, retinitis pigmentosa, pes cavus, ataxic and/or spastic gait disturbances with a progressive sensorimotor peripheral neuropathy. Other features include hyporeflexia, hyperreflexia, extensor plantar responses.
    • Sequence similaritiesBelongs to the serine esterase family.
    • Post-translational
      modifications
      Glycosylated.
    • Cellular localizationMembrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • 2-arachidonoylglycerol hydrolase antibody
      • 6330583M11Rik antibody
      • ABD12_HUMAN antibody
      • ABHD12 antibody
      • ABHD12A antibody
      • Abhydrolase domain containing protein 12 antibody
      • Abhydrolase domain-containing protein 12 antibody
      • AI431047 antibody
      • AW547313 antibody
      • BEM46L2 antibody
      • C20orf22 antibody
      • Monoacylglycerol lipase ABHD12 antibody
      • RP23-241M12.2 antibody
      see all

    Anti-ABHD12 antibody images

    References for Anti-ABHD12 antibody (ab81906)

    ab81906 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab81906.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"